These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3160228)

  • 21. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Spangenberg RB; Follansbee WP
    Circulation; 1983 Apr; 67(4):823-8. PubMed ID: 6218939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
    Amin DK; Shah PK; Hulse S; Shellock F
    Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of the new cardiotonic agent loprinone hydrochloride (E-1020) on left ventricular diameter in normal and experimental heart failure dogs and its action potential characteristics in isolated guinea pig cardiac muscles and sinus nodes].
    Ohhara H; Sawada K; Ogawa T; Takeda M; Igarashi T
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):421-33. PubMed ID: 1398339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM; Bristow MR; Mason JW
    Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
    Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological effects of intravenous MDL 17.043.
    Pop T; Treese N; Cremer GM; Haegele KD; Meyer J
    Int J Cardiol; 1986 Aug; 12(2):223-32. PubMed ID: 2943683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    Am J Cardiol; 1986 Jul; 58(1):110-6. PubMed ID: 2942027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one).
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(5):721-9. PubMed ID: 6182401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoximone improves selection of candidates for urgent cardiac transplantation.
    Loisance D; Benvenuti C; Dubois Randé JL; Deleuze P; Castaigne A; Cachera JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S23-7. PubMed ID: 2145234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of enoximone.
    Dage RC; Kariya T; Hsieh CP; Roebel LE; Cheng HC; Schnettler RA; Grisar JM
    Am J Cardiol; 1987 Aug; 60(5):10C-14C. PubMed ID: 2956861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
    Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
    Shah PK; Amin DK; Hulse S; Shellock F; Swan HJ
    Circulation; 1985 Feb; 71(2):326-31. PubMed ID: 3155500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
    Goto T; Nunoki K; Satoh K; Taira N
    Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
    Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.